Water-in-oil-in-water double emulsions: An excellent delivery system for improving the oral bioavailability of pidotimod in rats

Journal of Pharmaceutical Sciences

Volumn 100, Issue 6, 2011, Pages 2203-2211

  Qi, Xiaole ^a   Wang, Lishuang ^a   Zhu, Jiabi ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Bioavailability; Emulsion; Lymphatic transport; Oral drug delivery; Pharmacokinetics; Stability

Indexed keywords

MEDIUM CHAIN TRIACYLGLYCEROL; PHOSPHOLIPID; PIDOTIMOD; TRIACYLGLYCEROL;

AREA UNDER THE CURVE; ARTICLE; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG HALF LIFE; DRUG STABILITY; EMULSION; LYMPH FLOW; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; RAT; TIME TO MAXIMUM PLASMA CONCENTRATION; VISCOSITY;

EID: 79954521379     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22443     Document Type: Article

References (39)

1. Lipka E, Crison J, Amidon GL. 1996. Transmembrane transport of peptide type compounds: Prospects for oral delivery. J Control Release 39(2-3):121-129.
2. Onuki Y, Morishita M, Takayama K. 2004. Formulation optimization of water-in-oil-water multiple emulsion for intestinal insulin delivery. J Control Release 97(1):91-99.
3. Miyake M, Okay Y, Minami T, Toguchi H, Odomi M, Ogawara K, Higaki K, Kimura T. 2003. Combinatorial use of sodium laurate with taurine or l-glutamine enhances colonic absorption of rebamipide, poorly absorbable antiulcer drug, without any serious histopathological mucosal damages. J Pharm Sci 92(4):911-921.
4. Takatsuka S, Morita T, Koguchi A, Horikiri Y, Yamahara H, Yoshino H. 2006. Synergistic absorption enhancement of salmon calcitonin and reversible mucosal injury by applying a mucolytic agent and a non-ionic surfactant. Int J Pharm 316(1-2):124-130.
5. Bernkop-Schnurch A. 1998. The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins. J Control Release 52(1-2):1-16.
6. Janes KA, Calvo P, Alonso MJ. 2001. Polysaccharide colloidal particles as delivery systems for macromolecules. Adv Drug Deliv Rev 47(1):83-97.
7. Sakuma S, Hayashi M, Akashi M. 2001. Design of nanoparticles composed of graft copolymers for oral peptide delivery. Adv Drug Deliv Rev 47(1):21-37.
8. Asada H, Douen T, Waki M, Adachi S, Fujita T, Yamamoto A, Muranishi S. 1995. Absorption characteristics of chemically modified-insulin derivatives with various fatty acids in the small and large intestine. J Pharm Sci 84(6):682-687.
9. Wang J, Chow D, Heiati H, Shen WC. 2003. Reversible lipidization for the oral delivery of salmon calcitonin. J Control Release 88(3):369-380.
10. Buyukozturk F, Benneyan JC, Carrier RL. 2010. Impact of emulsion-based drug delivery systems on intestinal permeability and drug release kinetics. J Control Release 142(1):22-30.
11. Morishita M, Matsuzawa A, Takayama K, Isowa K, Nagai T. 1998. Improving insulin enteral absorption using water-in-oil-in-water emulsion. Int J Pharm 172:189-198.
12. Shima M, Tanaka M, Fujii T, Egawa K, Kimura Y, Adachi S, Matsuno R. 2006. Oral administration of insulin included in fine W/O/W emulsions to rats. Food Hydrocolloid 20:523-531.
13. Regan JO, Mulvihill DM. 2009. Water soluble inner aqueous phase markers as indicators of the encapsulation properties of water-in-oil-in-water emulsions stabilized with sodium caseinate. Food Hydrocolloid 23:2339-2345.
14. Regan JO, Mulvihill DM. 2010. Sodium caseinate-maltodextrin conjugate stabilized double emulsions: Encapsulation and stability. Food Res Int 43:224-231.
15. Benichou A, Aserin A, Garti N. 2007. W/O/W double emulsions stabilized with WPI-polysaccharide complexes. Colloid Surf A 294:20-32.
16. Koga K, Takarada N, Takada K. 2010. Nano-sized water-in-oil-in-water emulsion enhances intestinal absorption of calcein, a high solubility and low permeability compound. Eur J Pharm Biopharm 74(2):223-232.
17. Su J, Flanagan J, Hemar Y, Singh H. 2006. Synergistic effects of polyglycerol ester of polyricinoleic acid and sodium caseinate on the stabilisation of water-oil-water emulsions. Food Hydrocolloid 20:261-268.
18. Fechner A, Knoth A, Scherze I, Muschiolik G. 2007. Stability and release properties of double-emulsions stabilised by caseinate-dextran conjugates. Food Hydrocolloid 21:943-952.
19. Lutz R, Aserin A, Wicker L, Garti N. 2009. Double emulsions stabilized by a charged complex of modified pectin and whey protein isolate. Colloids Surf B Biointerfaces 72(1):121-127.
20. Terrisse I, Seiller M, Rabaron A, Grossiord JL, Magnet A, Hen-Ferrenbach C. 1993. Rheology: How to characterize and to predict the evolution of W/O/W multiple emulsions. Int J Cosmet Sci 15(2):53-62.
21. Hino T, Shimabayashi S, Tanaka M, Nakano M, Okochi H. 2001. Improvement of encapsulation efficiency of water-in-oil-in-water emulsion with hypertonic inner aqueous phase. J Microencapsul 18(1):19-28.
22. Ohwaki T, Machida R, Ozawa H. 1993. Improvement of the stability of water-in-oil-water multiple emulsions by the addition of surfactants in the internal aqueous phase of the emulsions. Int J Pharm 93:61-74.
23. Tokgoz NS, Grossiord JL, Fructus A, Seiller M, Prognon P. 1996. Evaluation of two fluorescent probes for the characterization of W/O/W emulsions. Int J Pharm 141:27-37.
24. Lindenstruth K, Muller BW. 2004. W/O/W multiple emulsions with diclofenac sodium. Eur J Pharm Biopharm 58(3):621-627.
25. Laugel C, Chaminade P, Baillet A, Seiller M, Ferrier D. 1996. Moisturizing substances entrapped in W/O/W emulsions: Analytical methodology for formulation, stability and release studies. J Control Release 38:59-67.
26. Alagona G, Ghio C, Villani V. 1999. Basis set, level, and continuum solvation effects on the stability of a synthetic dipeptide: PIDOTIMOD. J Phys Chem A 103:5823-5832.
27. Barchielli M, Coppi G. 1990. Activity of PGT/1A, a new immunostimulating drug, on macrophages and lymphocytes in immunodepressed mice. Acta Physiol Hung 75(Suppl):25-26.
28. Migliorati G, D'Adamio L, Coppi G, Nicoletti I, Riccardi C. 1992. Pidotimod stimulates natural killer cell activity and inhibits thymocyte cell death. Immunopharmacol Immunotoxicol 14(4):737-748.
29. Giagulli C, Noerder M, Avolio M, Becker PD, Fiorentini S, Guzman CA, Caruso A. 2009. Pidotimod promotes functional maturation of dendritic cells and displays adjuvant properties at the nasal mucosa level. Int Immunopharmacol 9(12):1366-1373.
30. Riboldi P, Gerosa M, Meroni PL. 2009. Pidotimod: A reappraisal. Int J Immunopathol Pharmacol 22(2):255-262.
31. Mailland F, Coppi G, Silingardi S. 1994. Pharmacokinetics and oral bioavailability of pidotimod in humans. Arzneimittelforschung 44(12A):1465-1469.
32. Bonnet M, Cansell M, Berkaoui A, Ropers MH, Anton M, Leal-Calderon F. 2009. Release rate profiles of magnesium from multiple W/O/W emulsions. Food Hydrocolloid 23:92-101.
33. Matsuzawa A, Morishita M, Takayama K, Nagai T. 1995. Absorption of insulin using water-in-oil-in-water emulsion from an enteral loop in rats. Biol Pharm Bull 18(12):1718-1723.
34. Dal Bo L, Broccali GP, Silingardi S, Coppi G. 1993. A new HPLC method for pidotimod plasma levels determination. Boll Chim Farm 132(4):126-128.
35. Schmidts T, Dobler D, Nissing C, Runkel F. 2009. Influence of hydrophilic surfactants on the properties of multiple W/O/W emulsions. J Colloid Interf Sci 338(1):184-192.
36. Su J, Flanagan J, Singh H. 2008. Improving encapsulation efficiency and stability of water-in-oil-in-water emulsions using a modified gum arabic [Acacia (sen) SUPER GUMTM]. Food Hydrocolloid 22:112-120.
37. Lee DW, Leinung MC, Grasso P. 2010. Oral delivery of mouse [D-Leu-4]-OB3, a synthetic peptide amide with leptin-like activity, in male Swiss Webster mice: A study comparing the pharmacokinetics of oral delivery to intraperitoneal, subcutaneous, intramuscular, and intranasal administration. Regul Pept 160(1-3):129-132.
38. Kato A, Ishibashi Y, Miyake Y. 1987. Effect of egg yolk lecithin on transdermal delivery of bunazosin hydrochloride. J Pharm Pharmacol 39(5):399-400.
39. Cano-Cebrian MJ, Zornoza T, Granero L, Polache A. 2005. Intestinal absorption enhancement via the paracellular route by fatty acids, chitosans and others: a target for drug delivery. Curr Drug Deliv 2(1):9-22.